tiprankstipranks
Willow Biosciences Inc (TSE:WLLW)
TSX:WLLW

Willow Biosciences Inc (WLLW) Financial Statements

33 Followers

Willow Biosciences Inc Financial Overview

Willow Biosciences Inc's market cap is currently ―. The company's EPS TTM is C$-0.085; its P/E ratio is -1.41; Willow Biosciences Inc is scheduled to report earnings on August 13, 2024, and the estimated EPS forecast is C$―. See an overview of income statement, balance sheet, and cash flow financials.
Mar 24Dec 23Sep 23Jun 23Mar 23
Income Statement-
Total RevenueC$ 51.00KC$ 89.00KC$ 674.00KC$ 135.00KC$ 274.00K
Gross ProfitC$ 51.00KC$ 89.00KC$ 674.00KC$ 135.00KC$ 274.00K
EBITC$ -2.32MC$ -2.68MC$ -2.23MC$ -3.58MC$ -4.77M
EBITDAC$ -1.97MC$ -2.30MC$ -1.67MC$ -3.14MC$ -4.32M
Net Income Common StockholdersC$ -2.36MC$ -2.42MC$ -2.23MC$ -3.60MC$ -4.77M
Balance Sheet-
Cash, Cash Equivalents and Short-Term InvestmentsC$ 1.64MC$ 3.17MC$ 3.68MC$ 6.49MC$ 10.49M
Total AssetsC$ 4.57MC$ 6.67MC$ 8.54MC$ 11.20MC$ 13.50M
Total DebtC$ 2.03MC$ 2.16MC$ 1.66MC$ 2.00MC$ 507.00K
Net DebtC$ 392.00KC$ -1.01MC$ -2.02MC$ -4.49MC$ -9.98M
Total LiabilitiesC$ 3.03MC$ 3.24MC$ 2.77MC$ 2.95MC$ 1.74M
Stockholders EquityC$ 1.54MC$ 3.44MC$ 5.76MC$ 8.26MC$ 11.77M
Cash Flow-
Free Cash FlowC$ -1.61MC$ -1.12M-C$ -3.69MC$ -4.34M
Operating Cash FlowC$ -1.75MC$ -1.07MC$ -2.65MC$ -3.68MC$ -3.82M
Investing Cash FlowC$ 135.00KC$ 4.00KC$ -14.00KC$ -1.00KC$ 3.48M
Financing Cash FlowC$ 71.00KC$ 267.00KC$ -115.00KC$ -296.00KC$ -174.00K
Currency in CAD

Willow Biosciences Inc Earnings and Revenue History

Willow Biosciences Inc Debt to Assets

Willow Biosciences Inc Cash Flow

Willow Biosciences Inc Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis